Novavax Inc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that includes ...
The recent run of good fortune for vaccine maker Novavax (NASDAQ:NVAX continues. Following the major licensing deal with ...
Novavax shares jumped 50% on Monday following its recent licensing deal with Sanofi, as meme stocks are making a 2021-style ...
opens new tab on Friday said it had struck a licensing deal worth ... well as royalties. Sanofi, one of the world's largest vaccine makers, will gain a license to co-sell Novavax's vaccine in ...
French drugmaker gains access to Covid shot and other tech Sanofi also takes a small stake in Maryland-based company -rte-company state="{"_id":"0000018f-638a-d4b6 ...
The biotech company said it would develop a combination Covid and flu shot with Sanofi as part of a billion-dollar deal.
Novavax (NVAX) shares are skyrocketing after the company announced a $1.2 billion deal with French drugmaker Sanofi (SNY). B.
Novavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined COVID-19 and ...
Furthermore, the company just inked a landmark partnership and licensing deal with French pharmaceutical giant Sanofi earlier ...
Novavax said the licensing agreement allows ... will co-market Novavax's Covid vaccine in most countries starting in 2025. The deal also allows Sanofi to use Novavax's Covid shot and flagship ...